Roivant May Take On AbbVie In Uveitis With Strong Phase II Efficacy

 
• By Joseph Haas
  
Uveitis
Roivant plans to move into Phase III with its non-infectious uveitis drug • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business